Trademark Overview
On Friday, August 15, 2025, a trademark application was filed for GLYCOPHOS with the United States Patent and Trademark Office. The USPTO has given the GLYCOPHOS trademark a serial number of 99340806. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, August 15, 2025. This trademark is owned by Fresenius Kabi AG. The GLYCOPHOS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely organic phosphate for treating nutritional conditions; Pharmaceutical preparations, namely, infusion solutions containing organic phosphate; Nutritional supplement containing organic phosphate; Intravenous fluids containing organic phosphate used for rehydration, nutrition and the delivery of pharmaceutical preparations; Nutritional supplements containing sodium glycerophosphate for parenteral nutrition in adult and pediatric patients when oral or enteral nutrition is not possible, insufficient, or contraindicated; Pharmaceutical preparations, namely, intravenous fluids to correct hypophosphatemia in adult and pediatric patients when oral or enteral replacement is not possible, insufficient, or contraindicated
